Average Co-Inventor Count = 4.95
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ortho-mcneil Pharmaceutical Corp. (7 from 363 patents)
2. Vertex Pharmaceuticals, Inc. (5 from 1,152 patents)
3. Ignyta, Inc. (5 from 25 patents)
4. Janssen Pharmaceutica Nv (3 from 2,078 patents)
5. Cephalon, Inc. (2 from 247 patents)
6. Sterling Winthrop Inc. (2 from 206 patents)
7. Sanoft (1 from 1 patent)
25 patents:
1. 10017496 - Uracil derivatives as AXL and c-MET kinase inhibitors
2. 9745283 - Uracil derivatives as AXL and c-MET kinase inhibitors
3. 9522902 - Uracil derivatives as AXL and c-MET kinase inhibitors
4. 9120778 - Uracil derivatives as AXL and c-MET kinase inhibitors
5. 9029538 - Uracil derivatives as AXL and c-MET kinase inhibitors
6. 8912183 - Substituted pyridazine derivatives
7. 8076331 - Substituted pyridazine derivatives
8. 8012963 - 3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors
9. 7749995 - 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors
10. 6841682 - Heterocycles useful in the treatment of benign prostatic hyperplasia
11. 6828327 - Macroheterocylic compounds useful as kinase inhibitors
12. 6780994 - Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
13. 6710048 - Pyrazine derivatives as modulators of tyrosine kinases
14. 6576614 - Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors
15. 6407080 - N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors